DCF — UNIVERSITY MEDICAL CTR. AT NEW ORLEA
Enterprise Value: $-593.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-593.7M
Enterprise Value
$-198.6M
PV of Cash Flows
$-395.1M
PV of Terminal Value
$-636.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $691.5M | $-31.1M | -4.0% | $-60.4M | $-54.9M |
| Year 2 | $712.2M | $-24.9M | -3.0% | $-55.1M | $-45.5M |
| Year 3 | $733.6M | $-18.3M | -2.0% | $-49.4M | $-37.1M |
| Year 4 | $755.6M | $-15.1M | -2.0% | $-47.1M | $-32.2M |
| Year 5 | $778.2M | $-13.6M | -2.0% | $-46.6M | $-28.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-593.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$671.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999940415351
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5